Web CRG
  1. Home
  2. Industry & Investors
  3. License CRG Technologies
  4. Technology Publisher

License CRG Technologies

Explore our Technology Portfolio

If you are exploring licensing opportunities at the CRG, the TBDO can guide you to a wide range of suitable researchers and their technologies.

Search Results - miguel+beato

1 Results Sort By:
NudTx: Targeting Cancer Stem Cells
Small molecules hits, and companion diagnostic, selective for the ATP generating activity of NUDT5. We are developing lead compounds that eventually could be used to complement poly ADP-ribose polymerase therapy or as a treatment on itself as an alternative treatment option to treat primary and metastatic cancers. Technology: Recurrence and metastasis...
Published: 10/4/2024   |   Inventor(s): Miguel Beato, Roni Wright
Keywords(s): Metastasis, Oncology
Category(s): Drug Targets & Mechanisms, Therapeutics (Biologics & Compounds)

 

 

Categories

Featured Technologies

Most Popular Keywords

Latest Technologies Published

Search our database for an up-to-date listing of CRG intellectual property available for licensing